Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$84.27

0.31 (0.37%)

12:44
03/20/17
03/20
12:44
03/20/17
12:44

Eli Lilly issues price transparency report, says net price rose 2.4% last year

Eli Lilly CEO Dave Ricks stated in a company blog post Monday: "Our discounts are now larger than ever. Lilly cut the average U.S. list price of our medicines by a full 50% last year via rebates and discounts. That's nearly twice as much as we did just five years ago - when the average discount was 28%. Because of these growing discounts, the average U.S. net price of Lilly medicines - the actual amount we recoup from selling our products - rose 2.4% last year. That's lower than overall medical inflation. Information about Lilly's list and net prices, and rebates and discounts, is now included in the '2016 Lilly Integrated Summary Report,' which we released today. We hope this greater level of transparency makes it easier for patients, physicians, policymakers, and others to understand our pricing." Reference Link

  • 20

    Mar

  • 22

    Mar

  • 19

    Apr

LLY Eli Lilly
$84.27

0.31 (0.37%)

01/19/17
SBSH
01/19/17
NO CHANGE
Target $100
SBSH
Buy
Eli Lilly story 'sharper' after solanezemab failure, says Citi
Citi analyst Andrew Baum believes Eli Lilly's (LLY) equity story has "become sharper" with the uncertainty of the failed solanezemab trial now removed. Recent and anticipated launches are set to drive an anticipated annual earnings growth rate of 13% over the next five years, Baum tells investors in a research note. He views the growth as attractive and continues to prefer Lilly and Bristol-Myers (BMY) among the U.S. major pharmaceutical names. The analyst lowered his price target for Lilly shares to $100 from $110 to reflect the failure in Alzheimer's and keeps a Buy rating on the name.
01/23/17
LEHM
01/23/17
DOWNGRADE
Target $45
LEHM
Equal Weight
CoLucid Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded CoLucid Pharmaceuticals (CLCD) to Equal Weight citing the takeover agreement by Eli Lilly (LLY). The analyst keeps a $45 price target for the shares.
03/16/17
03/16/17
DOWNGRADE

Eli Lilly delines 2%, or $1.36, to $84.52
03/20/17
UBSW
03/20/17
NO CHANGE
Target $85
UBSW
Neutral
Eli Lilly price target raised to $85 from $70 at UBS
UBS analyst Marc Goodman raised his price target on Eli Lilly to $85 from $70 as he updated his model to account for two months of IMS prescription data. Overall his 2017 revenues are largely unchanged but he raised his estimates slightly for 2018. Goodman also noted the positive upcoming data readouts are likely priced into the stock already. Goodman maintained a Neutral rating on Eli Lilly shares.

TODAY'S FREE FLY STORIES

TISA

Top Image Systems

$1.24

-0.0212 (-1.68%)

12:16
03/23/17
03/23
12:16
03/23/17
12:16
Hot Stocks
Breaking Hot Stocks news story on Top Image Systems »

Palogic Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
03/23/17
03/23
12:16
03/23/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
03/23/17
03/23
12:15
03/23/17
12:15
General news
Treasury Action: bonds are in limbo awaiting results the House ACA vote »

Treasury Action: bonds…

12:15
03/23/17
03/23
12:15
03/23/17
12:15
General news
Breaking General news story  »

Minneapolis Federal…

Z

Zillow

$35.29

0.12 (0.34%)

12:11
03/23/17
03/23
12:11
03/23/17
12:11
Options
Bearish flow in Zillow as shares falter »

Bearish flow in Zillow as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

12:10
03/23/17
03/23
12:10
03/23/17
12:10
General news
U.S. equities are dusting themselves off »

U.S. equities are dusting…

ATEC

Alphatec

$2.68

-0.12 (-4.29%)

12:08
03/23/17
03/23
12:08
03/23/17
12:08
Syndicate
Alphatec announces $18.9M private placement »

H.C. Wainwright is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$99.47

-0.075 (-0.08%)

12:08
03/23/17
03/23
12:08
03/23/17
12:08
Periodicals
SSL sues Orbital ATK over claims of confidential data theft, Reuters says »

Space Systems/Loral has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

TRIP

TripAdvisor

$41.40

-0.31 (-0.74%)

, PCLN

Priceline

$1,751.99

4.85 (0.28%)

12:06
03/23/17
03/23
12:06
03/23/17
12:06
Hot Stocks
TripAdvisor strength attributed to takeover speculation »

The intraday move up in…

TRIP

TripAdvisor

$41.40

-0.31 (-0.74%)

PCLN

Priceline

$1,751.99

4.85 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Conference/Events
Stephens transportation analysts hold an analyst/industry conference call »

Transportation Analysts…

BAC

Bank of America

$23.34

0.4 (1.74%)

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Options
Today's four most active single stock options are calls on BofA »

Today's four most…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$270.93

1.51 (0.56%)

12:01
03/23/17
03/23
12:01
03/23/17
12:01
Hot Stocks
Lockheed Martin to expand production for F-35 components in Johnstown »

Lockheed Martin will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

CEO

CNOOC

$118.68

3.25 (2.82%)

11:59
03/23/17
03/23
11:59
03/23/17
11:59
Upgrade
CNOOC rating change  »

CNOOC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$33.38

0.47 (1.43%)

11:59
03/23/17
03/23
11:59
03/23/17
11:59
Conference/Events
PolyOne management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 27

    Mar

GRBK

Green Brick

11:56
03/23/17
03/23
11:56
03/23/17
11:56
Hot Stocks
Green Brick Partners director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$19.68

0.14 (0.72%)

, SNY

Sanofi

$45.09

0.42 (0.94%)

11:56
03/23/17
03/23
11:56
03/23/17
11:56
Recommendations
Flexion, Sanofi analyst commentary  »

Flexion CFO departure…

FLXN

Flexion

$19.68

0.14 (0.72%)

SNY

Sanofi

$45.09

0.42 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 29

    Mar

  • 10

    May

  • 06

    Oct

SAN

Banco Santander

$6.12

0.005 (0.08%)

11:55
03/23/17
03/23
11:55
03/23/17
11:55
Hot Stocks
Santander to improve consumer protections in Fed agreement »

Santander has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
03/23/17
03/23
11:55
03/23/17
11:55
Conference/Events
Federal Reserve Bank of Minneapolis President speaks at conference »

Minneapolis Federal…

MAA

MAA

$101.99

0.72 (0.71%)

11:54
03/23/17
03/23
11:54
03/23/17
11:54
Conference/Events
MAA management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

ADP

ADP

$103.68

0.56 (0.54%)

, CSOD

Cornerstone OnDemand

$38.36

-0.14 (-0.36%)

11:53
03/23/17
03/23
11:53
03/23/17
11:53
Conference/Events
Stephens enterprise software analysts hold an analyst/industry conference call »

Enterprise Software…

ADP

ADP

$103.68

0.56 (0.54%)

CSOD

Cornerstone OnDemand

$38.36

-0.14 (-0.36%)

ORCL

Oracle

$44.97

0.175 (0.39%)

PAYC

Paycom

$54.22

-1.06 (-1.92%)

PCTY

Paylocity

$35.16

-0.16 (-0.45%)

SAP

SAP

$98.09

0.44 (0.45%)

ULTI

Ultimate Software

$193.35

1.24 (0.65%)

WDAY

Workday

$81.64

0.19 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 08

    Jun

  • 20

    Jun

TRP

TransCanada

$46.42

0.25 (0.54%)

11:52
03/23/17
03/23
11:52
03/23/17
11:52
Periodicals
State Department expected to approve Keystone XL pipeline permit, Politico says »

The U.S. State Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$10.02

-0.1 (-0.99%)

11:51
03/23/17
03/23
11:51
03/23/17
11:51
Options
Vote of confidence in the US Oil Fund »

Vote of confidence in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$108.45

2.36 (2.22%)

11:45
03/23/17
03/23
11:45
03/23/17
11:45
Periodicals
Alibaba looking to move beyond China, Nikkei says »

Alibaba is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
03/23/17
03/23
11:45
03/23/17
11:45
General news
Breaking General news story  »

Minneapolis Federal…

GOOG

Alphabet

$829.59

-0.87 (-0.10%)

11:42
03/23/17
03/23
11:42
03/23/17
11:42
Periodicals
Google says 'extensive' review of advertising policies begun, Reuters says »

According to Reuters, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 02

    May

  • 22

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.